Alzheimer's and Brain Research Center | Alzheimer's Association


Alzheimer's Assocation Research only
All of alz.org
  • Go to Alz.org
  • Research Center
  • AAIC
  • ISTAART
  • Journal
  • Grants
  • TrialMatch
  • Press
  • Donate
  • Contact Us
Home
Science and Progress
Clinical Trials
Funding and Collaboration
You can Help
Stay Current
Video and Resources

Text Size

Small text Medium text Large text
 

A future without Alzheimer's

The race is on. Alzheimer's and related dementias research is a dynamic field, and momentum builds each year. This site is for professional researchers and anyone interested in following the progress in research. The Alzheimer's Association has been involved in every major advancement in Alzheimer's and related dementias research since the 1980's and is a leader in the global fight for a world without Alzheimer's.

 

what we know today

tomorrow's answers

clinical trials

Brain, Alzheimer’s, dementia and neuroscience research.
 

Research Updates

spotlight

 

November 29, 2012

New grants to fund research to better treat Alzheimer's in people with Down syndrome
The Alzheimer's Association, the Linda Crnic Institute for Down Syndrome and the Global Down Syndrome Foundation today launched a new research initiative to better understand the development of Alzheimer's disease in individuals with Down syndrome and translate the research into improved treatments for people at risk to develop Alzheimer's.
> Read more
- Alzheimer's Association

October 21, 2012

International Research Grant Program reaches a milestone
In its 30th year of supporting Alzheimer's research through its International Research Grant Program (IRGP), the Alzheimer’s Association has reached a milestone — since 1982 it has awarded more than $300 million to over 2,100 scientists around the globe. This includes the 2012 IRGP awards of more than $12 million to 70-plus investigators in 12 countries.
> Read more
- Alzheimer's Association

October 11, 2012

DIAN Announces Drugs to Be Tested for Alzheimer’s Prevention
Three drugs have been chosen for testing by the Dominantly Inherited Alzheimer Network (DIAN) – Trials Unit for their potential to prevent Alzheimer's. Clinical trials of the drugs — gantenerumab,solanezumab and a beta-secretase inhibitor—are expected to begin in early 2013.
> Three Drugs to Be Tested to Stave Off Alzheimer’s
- New York Times








ALL AAIC NEWS AND PHOTO GALLERY

ALL UPDATES


2013 Research Grant Program Announcement

Application procedures and key dates now available


Amyloid Imaging Task Force Seeks Input

Share feedback on appropriate use criteria for clinical amyloid imaging. New deadline: December 6


Global Alzheimer’s Association Interactive Network

A collaborative project to transform the way scientists work together


Alzheimer's Association TrialMatch™

A free service to help connect people with clinical trials


World Wide Alzheimer's Disease Neuroimaging Initiative (ADNI)

A collaborative effort of scientists from around the world

get e-updates

 
  Zip:

you can help

Blog Facebook twitter flickr You Tube

 

 

Alzheimer's & Dementia® Journal

 

Current Issue  |  November 2012  |  Vol. 8, No. 6

ABOUT THE JOURNAL

   
 

Key awareness milestones


 

Key events during the past 100 years spurred public awareness of Alzheimer's disease and ignited a massive research effort to learn more.

See more milestones

 

Our research strategy

The Alzheimer's Association is committed to accelerating the global effort to eliminate Alzheimer's disease. We are the largest private, nonprofit funder of Alzheimer's research. We believe in the value of collaboration and are willing to imagine a time when we will have disease-modifying treatments, preventive strategies and gold-standard care for all people affected by Alzheimer's disease.

More about the Alzheimer's Association commitment to research.